"Vancomycin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nonsusceptibility of bacteria to the action of VANCOMYCIN, an inhibitor of cell wall synthesis.
Descriptor ID |
D020713
|
MeSH Number(s) |
G06.099.225.984 G06.225.347.984 G07.690.773.984.269.347.984
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vancomycin Resistance".
Below are MeSH descriptors whose meaning is more specific than "Vancomycin Resistance".
This graph shows the total number of publications written about "Vancomycin Resistance" by people in this website by year, and whether "Vancomycin Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 1 | 2 |
2002 | 4 | 0 | 4 |
2003 | 1 | 1 | 2 |
2004 | 3 | 0 | 3 |
2005 | 2 | 1 | 3 |
2006 | 2 | 0 | 2 |
2007 | 2 | 0 | 2 |
2010 | 1 | 2 | 3 |
2011 | 1 | 2 | 3 |
2012 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2020 | 1 | 1 | 2 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vancomycin Resistance" by people in Profiles.
-
Multisite Detection of Tn1549-Mediated vanB Vancomycin Resistance in Multidrug-Resistant Enterococcus faecalis ST6 in Texas and Florida. Antimicrob Agents Chemother. 2023 01 24; 67(1):e0128422.
-
Impact of Inappropriate Antibiotic Therapy in Vancomycin-Resistant Enterococcus Bacteremia. Am J Ther. 2020 Sep 04; 28(4):e388-e396.
-
Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates. J Antimicrob Chemother. 2020 04 01; 75(4):859-867.
-
Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections. Antimicrob Agents Chemother. 2017 03; 61(3).
-
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2013 Oct; 41(5):1039-40.
-
Evaluation of a daptomycin dose-optimization protocol. Am J Health Syst Pharm. 2012 Jun 01; 69(11):979-84.
-
Novel intervention for eliminating VRE from the environment. Arch Intern Med. 2011 Oct 10; 171(18):1684-5.
-
Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med. 2011 Sep 08; 365(10):892-900.
-
Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on hospital operations and microbial reduction. Infect Control Hosp Epidemiol. 2011 Mar; 32(3):286-8.
-
The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin. J Antimicrob Chemother. 2010 Oct; 65(10):2267-70.